No Detail Found!

Effect of COVID-19 vaccination on menstrual cycle irregularities among females: A cross-sectional study in Pakistan

Author(s)
Alina Arshad Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University,Lahore,Pakistan
Muhammad Usman Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences,Lahore,Pakistan
Humaira Majeed Khan Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University,Lahore,Pakistan
Zaufishan Rahman Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University,Lahore,Pakistan
Mobina Manzoor Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University,Lahore,Pakistan
Bazgha Gul Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University,Lahore,Pakistan
Abstract
This study was aimed to assess the type and severity of COVID vaccine-induced menstrual disorders and also to investigate the risk factors for menstrual changes following COVID-19 vaccination in Pakistani females. A crosssectional survey-based study was conducted in females between 12 -70 years of age from February to July 2022. The survey was conducted via in-person interviews as well as via social media. The data was analyzed using standard descriptive statistical parameters, the sociodemographic and clinical features were evaluated and reported as frequencies (percentages). The study comprised a total of 1023 female subjects. Approximately 36.9% of women reported menstrual abnormalities following immunization, with 30.5% experiencing them following their second dose. However, in majority of these women (21%) the symptoms were resolved after 3 months of irregularity. Vaccine type significantly influenced the incidence of menstrual disorders (p<0.001) which were linked to Pfizer-Biontech, Sinopahrm, Sinovac, Moderna at rates of 14.9%, 9.5%, 4.7% and 2.7%, respectively. Both AstraZeneca and Moderna were implicated in postmenopausal bleeding (1.6% and 0.8%, respectively). The study showed that females receiving COVID-19 vaccines experienced menstrual irregularities such as short duration of periods, decreased volume of bleeding, and frequent menstrual cycles. However, the symptoms were temporary and self-limiting.
Publication Details
Page(s) 215-222
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
COVID-19, Pakistan, vaccination, Covid-19, menstrual abnormalities
0

Citations

0

Downloads

66

Views